Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-02-21 @ 11:35 PM
Study NCT ID:
NCT03108495
Status:
TERMINATED
Last Update Posted:
2025-09-17
First Post:
2017-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Sponsor:
Iovance Biotherapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-145-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None